Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT 2 ) angiotensin receptor
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
The vast majority of the known biological effects of the renin–angiotensin system are mediated by the type-1 (AT 1 ) receptor, and the functions of the type-2 (AT 2 ) receptor are largely unknown. We investigated the role of the AT 2 receptor in the vascular and renal responses to physiological increases in angiotensin II (ANG II) in mice with targeted deletion of the AT 2 receptor gene. Mice lacking the AT 2 receptor (AT 2 -null mice) had slightly elevated systolic blood pressure (SBP) compared with that of wild-type (WT) control mice ( P < 0.0001). In AT 2 -null mice, infusion of ANG II (4 pmol/kg/min) for 7 days produced a marked and sustained increase in SBP [from 116 ± 0.5 to 208 ± 1 mmHg ( P < 0.0001) (1 mmHg = 133 Pa)] and reduction in urinary sodium excretion (U Na V) [from 0.6 ± 0.01 to 0.05 ± 0.002 mM/day ( P < 0.0001)] whereas neither SBP nor U Na V changed in WT mice. AT 2 -null mice had low basal levels of renal interstitial fluid bradykinin (BK), and cyclic guanosine 3′,5′-monophosphate, an index of nitric oxide production, compared with WT mice. In WT mice, dietary sodium restriction or ANG II infusion increased renal interstitial fluid BK, and cyclic guanosine 3′,5′-monophosphate by ≈4-fold ( P < 0.0001) whereas no changes were observed in AT 2 -null mice. These results demonstrate that the AT 2 receptor is necessary for normal physiological responses of BK and nitric oxide to ANG II. Absence of the AT 2 receptor leads to vascular and renal hypersensitivity to ANG II, including sustained antinatriuresis and hypertension. These results strongly suggest that the AT 2 receptor plays a counterregulatory protective role mediated via BK and nitric oxide against the antinatriuretic and pressor actions of ANG II.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor
Ichiki, T., Labosky, P. A., Shiota, C., Okuyama, S., Imagawa, Y., Fogo, A., Niimura, F., Ichikawa, I., Hogan, B. L. M., & lnagami, T. (1995) · Nature · doi:10.1038/377748a0 · Cited by 858
Self-citationBehavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice
Hein, L., Barsh, G. S., Pratt, R. E., Dzau, V. J., & Kobilka, B. K. (1995) · Nature · doi:10.1038/377744a0 · Cited by 742
Angiotensin Receptors and Their Antagonists
Goodfriend, T. L., Elliott, M. E., & Catt, K. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606203342507 · Cited by 558
Siragy, H. M., & Carey, R. M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119531 · Cited by 485
Self-citationAT2Receptor Stimulation Increases Aortic Cyclic GMP in SHRSP by a Kinin-Dependent Mechanism
Gohlke, P., Pees, C., & Unger, T. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.349 · Cited by 395
Expression of the Subtype 2 Angiotensin (AT2) Receptor Protein in Rat Kidney
Ozono, R., Wang, Z.-Q., Moore, A. F., Inagami, T., Siragy, H. M., & Carey, R. M. (1997) · Hypertension · doi:10.1161/01.hyp.30.5.1238 · Cited by 317
Self-citationSiragy, H. M., & Carey, R. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118630 · Cited by 314
Self-citationMasaki, H., Kurihara, T., Yamaki, A., Inomata, N., Nozawa, Y., Mori, Y., Murasawa, S., Kizima, K., Maruyama, K., Horiuchi, M., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1885 · Cited by 260
BIOLOGICAL FUNCTIONS OF ANGIOTENSIN AND ITS RECEPTORS
Matsusaka, T., & Ichikawa, I. (1997) · Annual Review of Physiology · doi:10.1146/annurev.physiol.59.1.395 · Cited by 224
Downregulation of Angiotensin II Type 1 Receptor Gene Transcription by Nitric Oxide
Ichiki, T., Usui, M., Kato, M., Funakoshi, Y., Ito, K., Egashira, K., & Takeshita, A. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.342 · Cited by 211
Self-citation
Cited by
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
de Gasparo, M., Catt, K. J., Inagami, T., Wright, J. W., & Unger, T. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01458-3 · Cited by 2,132
Self-citationKobori, H., Nangaku, M., Navar, L. G., & Nishiyama, A. (2007) · Pharmacological Reviews · doi:10.1124/pr.59.3.3 · Cited by 1,237
Carey, R. M., & Siragy, H. M. (2003) · Endocrine Reviews · doi:10.1210/er.2003-0001 · Cited by 603
Self-citationmTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice
Inoki, K., Mori, H., Wang, J., Suzuki, T., Hong, S., Yoshida, S., Blattner, S. M., Ikenoue, T., Rüegg, M. A., Hall, M. N., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44771 · Cited by 538
Sodium-Potassium-Adenosinetriphosphatase-Dependent Sodium Transport in the Kidney: Hormonal Control
Féraille, E., & Doucet, A. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.1.345 · Cited by 500
Angiotensin II Type 2 Receptor Signaling Attenuates Aortic Aneurysm in Mice Through ERK Antagonism
Habashi, J. P., Doyle, J. J., Holm, T. M., Aziz, H., Schoenhoff, F., Bedja, D., Chen, Y., Modiri, A. N., Judge, D. P., & Dietz, H. C. (2011) · Science · doi:10.1126/science.1192152 · Cited by 472
Angiotensin AT1/AT2 Receptors: Regulation, Signalling and Function
KASCHINA, E., & UNGER, T. (2003) · Blood Pressure · doi:10.1080/08037050310001057 · Cited by 458
Li, X. C., Zhang, J., & Zhuo, J. L. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.06.005 · Cited by 435
Role of the Angiotensin Type 2 Receptor in the Regulation of Blood Pressure and Renal Function
Carey, R. M., Wang, Z.-Q., & Siragy, H. M. (2000) · Hypertension · doi:10.1161/01.hyp.35.1.155 · Cited by 431
Self-citationImmune and Inflammatory Role in Renal Disease
Imig, J. D., & Ryan, M. J. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c120028 · Cited by 356
Mutant G-protein-coupled receptors as a cause of human diseases
Schöneberg, T., Schulz, A., Biebermann, H., Hermsdorf, T., Römpler, H., & Sangkuhl, K. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.08.008 · Cited by 337
Durvasula, R. V., Petermann, A. T., Hiromura, K., Blonski, M., Pippin, J., Mundel, P., Pichler, R., Griffin, S., Couser, W. G., & Shankland, S. J. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00362.x · Cited by 313
Karnik, S. S., Unal, H., Kemp, J. R., Tirupula, K. C., Eguchi, S., Vanderheyden, P. M. L., & Thomas, W. G. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.010454 · Cited by 302
Ichihara, S., Senbonmatsu, T., Price, E., Ichiki, T., Gaffney, F. A., & Inagami, T. (2001) · Circulation · doi:10.1161/01.cir.104.3.346 · Cited by 299
Self-citationDaugherty, A., Manning, M. W., & Cassis, L. A. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704331 · Cited by 289
Identification and characterization of a functional mitochondrial angiotensin system
Abadir, P. M., Foster, D. B., Crow, M., Cooke, C. A., Rucker, J. J., Jain, A., Smith, B. J., Burks, T. N., Cohn, R. D., Fedarko, N. S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101507108 · Cited by 279
Self-citationAngiotensin receptors: distribution, signalling and function
DINH, D. T., FRAUMAN, A. G., JOHNSTON, C. I., & FABIANI, M. E. (2001) · Clinical Science · doi:10.1042/cs1000481 · Cited by 268
Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide
Berry, C., Touyz, R., Dominiczak, A. F., Webb, R. C., & Johns, D. G. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.281.6.h2337 · Cited by 259
AT2 receptors: Functional relevance in cardiovascular disease
Jones, E. S., Vinh, A., McCarthy, C. A., Gaspari, T. A., & Widdop, R. E. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.08.009 · Cited by 237
“Moreover, PD123319 reversed the natriuretic and diuretic effects of candesartan, suggesting an involvement of AT2R in the effect of the latter compound (Hakam & Hussain, 2005), consistent with earlier studies (Siragy & Carey, 1999; Siragy et al., 1999).”
ResultThe “His and Hers” of the Renin-Angiotensin System
Hilliard, L. M., Sampson, A. K., Brown, R. D., & Denton, K. M. (2013) · Current Hypertension Reports · doi:10.1007/s11906-012-0319-y · Cited by 228
“This finding recapitulated previous findings in mice that the AT2R modulates pressure-natriuresis in males [78, 79], but was the first study to demonstrate that it does so to a similar extent in females.”
ResultAngiotensin AT2 receptors: cardiovascular hope or hype?
Widdop, R. E., Jones, E. S., Hannan, R. E., & Gaspari, T. A. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705448 · Cited by 223
“Genetic studies involving either the targeted deletion of the AT2R gene (Siragy et al., 1999a) or AT2 receptor over expression in VSMC of transgenic mice (Tsutsumi et al., 1999) have provided further support for a link between AT2Rmediated vasodepression and associated bradykinin and/or NO…”
BackgroundInfluentialThe angiotensin II type 2 receptor: an enigma with multiple variations
Gallinat, S., Busche, S., Raizada, M. K., & Sumners, C. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.278.3.e357 · Cited by 174
“Recent studies indicate that, in AT2 receptor knockout mice, ANG II infusion for 7 days results in a sustained increase in systolic blood pressure and a reduction in urinary sodium excretion, whereas neither systolic blood pressure nor a reduction in urinary sodium excretion changed in wild-type mice (132).”
BackgroundThe Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target
Steckelings, U. M., Widdop, R. E., Sturrock, E. D., Lubbe, L., Hussain, T., Kaschina, E., Unger, T., Hallberg, A., Carey, R. M., & Sumners, C. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000281 · Cited by 97
Self-citationLoria, A. S., Kang, K.-T., Pollock, D. M., & Pollock, J. S. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.168674 · Cited by 48
Chen, H., Peng, J., Wang, T., Wen, J., Chen, S., Huang, Y., & Zhang, Y. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115370 · Cited by 19
Metadata
- Authors
- Siragy, H. M., Inagami, T., Ichiki, T., & Carey, R. M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1999-05-25
- Volume
- 96
- Issue
- 11
- Pages
- 6506-6510
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1980182090
- Cited by
- 328
- References
- 18
- FWCI
- 21.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.